A path to faster and more cost-effective drug development

Researchers at Rensselaer Polytechnic Institute (RPI) have published research in Molecular Pharmaceutics predicting how proteins interact in drug development. The research is a collaboration between Amgen and the University ...

Preventing resistance in cancer therapy

The latest developmental drugs, particularly for use in oncology, rely on the targeted degradation of harmful pathogenic proteins. In a recent study published in Nature Chemical Biology, researchers at CeMM, the Research ...

Efflux pump inhibitors: Bulking up to beat bacteria

The medical profession is in the midst of losing an arms race. Bacterial antibiotic resistance doesn't just threaten our ability to treat infection but our ability to carry out any treatment where infection is a risk. This ...

page 8 from 40